Physiotherapy Department, 4th Floor Philip Block, the Alfred, Alfred Health, Melbourne, VIC, Australia.
Level 4, The Alfred Centre, La Trobe University, Melbourne, VIC, Australia.
Physiother Theory Pract. 2023 Jul 3;39(7):1406-1416. doi: 10.1080/09593985.2022.2041779. Epub 2022 Feb 22.
Postoperative rehabilitation is crucial following lung transplantation (LTx); however, it is unclear whether intensive rehabilitation is feasible to deliver in the acute setting. We aimed to establish the feasibility and safety of intensive acute physiotherapy post-LTx.
This feasibility trial randomized 40 adults following bilateral sequential LTx to either standard (once-daily) or intensive (twice-daily) physiotherapy. Primary outcomes were feasibility (recruitment and delivery of intensive intervention) and safety. Secondary outcomes included six-minute walk test; 60-second sit-to-stand; grip strength; physical activity; pain; EQ-5D-5L; length of stay; and readmissions. Data were collected at baseline, week 3, and week 10 post-LTx. ClinicalTrials.gov #NCT03095859.
Of 83 LTx completed during the trial, 49% were eligible and 48% provided consent. Median age was 61 years {range 18-70}; waitlist time 85 days [IQR 35-187]. Median time to first mobilization was 2 days [2-3]. Both groups received a median of 10 [7-14] standard interventions post-randomization. A median of 9 [6-18] individual intensive interventions were attempted (86% successful), the most common barrier being medical procedures/investigations (67%). No intervention-related adverse events or between-group differences in secondary outcomes were observed.
Acute, intensive physiotherapy was feasible and safe post-LTx. This trial provides data to underpin definitive trials to establish efficacy.
肺移植(LTx)后康复至关重要;然而,目前尚不清楚在急性期是否可以进行强化康复治疗。我们旨在确定 LTx 后强化急性物理治疗的可行性和安全性。
这项可行性试验将 40 名双侧序贯 LTx 后的成年人随机分为标准(每日一次)或强化(每日两次)物理治疗组。主要结局是可行性(强化干预的招募和实施)和安全性。次要结局包括 6 分钟步行试验;60 秒坐立站起;握力;身体活动;疼痛;EQ-5D-5L;住院时间;和再入院率。数据在 LTx 后基线、第 3 周和第 10 周收集。ClinicalTrials.gov #NCT03095859。
在试验期间完成的 83 例 LTx 中,49%符合条件,48%同意参与。中位年龄为 61 岁{范围 18-70};等待时间 85 天[IQR 35-187]。首次活动的中位时间为 2 天[2-3]。两组在随机分组后均接受了中位数为 10[7-14]次标准干预。中位数尝试了 9[6-18]次个体化强化干预(成功率为 86%),最常见的障碍是医疗程序/检查(67%)。未观察到与干预相关的不良事件或组间次要结局差异。
LTx 后急性强化物理治疗是可行且安全的。这项试验提供了数据来支持确定疗效的确定性试验。